Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.72 |
| ▸ | CA12 | O43570 | 2/20 | 0.72 |
| ▸ | F13A1 | P00488 | 2/20 | 0.72 |
| ▸ | CA2 | P00918 | 2/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.72 |
| ▸ | CA4 | P22748 | 2/20 | 0.72 |
| ▸ | CA6 | P23280 | 2/20 | 0.72 |
| ▸ | CA5A | P35218 | 2/20 | 0.72 |
| ▸ | THPO | P40225 | 2/20 | 0.72 |
| ▸ | CA7 | P43166 | 2/20 | 0.72 |
| ▸ | CA9 | Q16790 | 2/20 | 0.72 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.72 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.72 |
| ▸ | CASP2 | P42575 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | RECQL | P46063 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13522294 | 1.00 | TSHR (0.72) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL197215 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL11881064 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL443775 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL2166878 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL964709 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL962833 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL9807857 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| SCHEMBL22580330 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 | |
| Methane SCHEMBL4539643 | 0.97 | TSHR (0.68) | TSHRCA12F13A1CA2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022167700-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | Floratek Pharma SA (CH) | 2022-08-11 | — | — | WO | claimed |
| EP-2098316-A2 | Metal nanoparticles stabilized with a bident amine | Xerox Corporation (US) | 2009-09-09 | — | — | EP | claimed |
| US-20090214764-A1 | METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | claimed |
| US-4292411-A | ORGANIC BISMUTH COMPOUND, PRIMARY OR SECONDARY AMINE | S.A. PRB (BE) | 1981-09-29 | — | — | US | claimed |
| US-4150206-A | SYNERGISTIC CATALYSTS | S.A. PRB (BE) | 1979-04-17 | — | — | US | claimed |
| US-3937856-A | REHABILITATION OF WATER-DAMAGED ELECTRICAL EQUIPMENT | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-10 | — | — | US | claimed |
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| US-20240132461-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | FLORATEK PHARMA S A (CH) | 2024-04-25 | — | — | US | disclosed |
| EP-4288421-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | Floratek Pharma SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| EP-4288421-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | Floratek Pharma SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023208988-A1 | ANTIBACTERIAL COMPOUNDS ELIMINATING DORMANT BACTERIAL CELLS | UNIVERSITÉ D'AIX-MARSEILLE (FR) | 2023-11-02 | — | — | WO | disclosed |
| US-20230313195-A1 | NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE | Suzhou Ribo Life Science Co., Ltd. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230302138-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | RECODE THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| EP-2098316-A2 | Metal nanoparticles stabilized with a bident amine | Xerox Corporation (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20090214764-A1 | METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | disclosed |
| US-7517913-B2 | Polyamine conjugates with acidic retinoids and preparation thereof | PAPAIOANNOU DIONYSIOS | 2009-04-14 | — | — | US | disclosed |
| US-20080299669-A1 | Methods and devices for analytical sensing of biogenic amines | SOUTH CAROLINA, UNIVERSITY OF | 2008-12-04 | — | — | US | disclosed |
| US-7208528-B1 | Polyamine analogues as therapeutic and diagnostic agents | MEDIQUEST THERAPEUTICS, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-4003718-A | Substituted tetrahydropyrimidines | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1977-01-18 | — | — | US | disclosed |
| US-3937856-A | REHABILITATION OF WATER-DAMAGED ELECTRICAL EQUIPMENT | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302138-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | CHMP4B, LIPA, NPC1L1 | TSHR 2262/4885CA12 986/4885F13A1 1134/4885 |
| US-20240132461-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | SRM, TP53, KDM5A | TSHR 4358/4885CA12 2797/4885F13A1 2114/4885 |
| US-20230313195-A1 | NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE | PCSK9, PCSK7, PCSK6 | TSHR 4123/4885CA12 4469/4885F13A1 613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.